Anand Anbarasu

3.6k total citations
167 papers, 2.7k citations indexed

About

Anand Anbarasu is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Anand Anbarasu has authored 167 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 42 papers in Molecular Medicine and 32 papers in Infectious Diseases. Recurrent topics in Anand Anbarasu's work include Antibiotic Resistance in Bacteria (42 papers), Computational Drug Discovery Methods (24 papers) and Tuberculosis Research and Epidemiology (15 papers). Anand Anbarasu is often cited by papers focused on Antibiotic Resistance in Bacteria (42 papers), Computational Drug Discovery Methods (24 papers) and Tuberculosis Research and Epidemiology (15 papers). Anand Anbarasu collaborates with scholars based in India, United Kingdom and United States. Anand Anbarasu's co-authors include Sudha Ramaiah, Sravan Kumar Miryala, Soumya Basu, Rayapadi G. Swetha, P. Lavanya, P. Anitha, Malathi Kullappan, Reetika Debroy, Aniket Naha and Balaji Veeraraghavan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Microbiology.

In The Last Decade

Anand Anbarasu

159 papers receiving 2.6k citations

Peers

Anand Anbarasu
Sudha Ramaiah India
L.J. Worrall Canada
Syed Sikander Azam Pakistan
Sajjad Ahmad Pakistan
André Mateus Sweden
Diógenes Santiago Santos Brazil
Sanjib Bhakta United Kingdom
Michael N. Gwynn United States
Yusuf Akhter India
Maya A. Farha Canada
Sudha Ramaiah India
Anand Anbarasu
Citations per year, relative to Anand Anbarasu Anand Anbarasu (= 1×) peers Sudha Ramaiah

Countries citing papers authored by Anand Anbarasu

Since Specialization
Citations

This map shows the geographic impact of Anand Anbarasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Anbarasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Anbarasu more than expected).

Fields of papers citing papers by Anand Anbarasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand Anbarasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Anbarasu. The network helps show where Anand Anbarasu may publish in the future.

Co-authorship network of co-authors of Anand Anbarasu

This figure shows the co-authorship network connecting the top 25 collaborators of Anand Anbarasu. A scholar is included among the top collaborators of Anand Anbarasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand Anbarasu. Anand Anbarasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Swetha, Rayapadi G., et al.. (2024). Immunoinformatics strategy for designing a multi-epitope chimeric vaccine to combat Neisseria gonorrhoeae. 25(3). 385–402. 1 indexed citations
3.
Swetha, Rayapadi G., et al.. (2024). Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines. Biologicals. 87. 101782–101782. 17 indexed citations
4.
Basu, Soumya, Balaji Veeraraghavan, & Anand Anbarasu. (2024). Anti-bacterial compounds from Indian curry-leaf tree Murraya koenigii have potential to inhibit carbapenem-resistant Streptococcus pneumoniae. Clinical Epidemiology and Global Health. 28. 101511–101511. 5 indexed citations
5.
6.
Manoharan, Anand, et al.. (2024). Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and breakthroughs. Archives of Microbiology. 206(9). 382–382. 7 indexed citations
7.
Basu, Soumya, et al.. (2024). Coinfections in human papillomavirus associated cancers and prophylactic recommendations. Reviews in Medical Virology. 34(2). e2524–e2524. 3 indexed citations
8.
Manoharan, Anand, et al.. (2024). Computational study of the piperidine and FtsZ interaction in Salmonella Typhi: implications for disrupting cell division machinery. Journal of Biomolecular Structure and Dynamics. 43(12). 5886–5899. 3 indexed citations
9.
Alasmari, Abdullah F., et al.. (2024). Transcriptomic, mutational and structural bioinformatics approaches to explore the therapeutic role of FAP in predominant cancer types. Discover Oncology. 15(1). 699–699. 1 indexed citations
10.
Anbarasu, Anand, et al.. (2023). Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review. Medical Oncology. 40(6). 171–171. 10 indexed citations
11.
Anbarasu, Anand, et al.. (2023). Elucidating the molecular role of MUC5B in progressive lung adenocarcinoma: Prospects for early diagnosis. Journal of Molecular Recognition. 37(1). e3064–e3064. 6 indexed citations
12.
13.
Miryala, Sravan Kumar, Anand Anbarasu, & Sudha Ramaiah. (2021). Gene interaction network to unravel the role of gut bacterial species in cardiovascular diseases: E. coli O157:H7 host-bacterial interaction study. Computers in Biology and Medicine. 133. 104417–104417. 16 indexed citations
14.
Vadakkan, Kayeen, J. Hemapriya, Anand Anbarasu, Sudha Ramaiah, & S. Vijayanand. (2020). Quorum quenching by 2-Hydroxyanisole extracted from Solanum torvum on Pseudomonas aeruginosa and its inhibitory action upon LasR protein. Gene Reports. 21. 100802–100802. 11 indexed citations
15.
Anbarasu, Anand, Sudha Ramaiah, & Paul G. Livingstone. (2020). Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?. Human Vaccines & Immunotherapeutics. 16(9). 2217–2218. 37 indexed citations
16.
Kullappan, Malathi, et al.. (2018). FtsA as a cidal target for Staphylococcus aureus: Molecular docking and dynamics studies. Journal of Cellular Biochemistry. 120(5). 7751–7758. 30 indexed citations
17.
Swetha, Rayapadi G., Sudha Ramaiah, Anand Anbarasu, & K. Sekar. (2016). Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses. PubMed. 2016. 1–4. 3 indexed citations
18.
19.
Anbarasu, Anand, et al.. (2014). Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins. Molecular BioSystems. 10(4). 891–900. 74 indexed citations
20.
Lavanya, P., Rayapadi G. Swetha, P. Anitha, et al.. (2013). Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation. 9(18). 889–895. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sudha Ramaiah Breakdown of academic impact, for papers by L.J. Worrall Breakdown of academic impact, for papers by Syed Sikander Azam Breakdown of academic impact, for papers by Sajjad Ahmad Breakdown of academic impact, for papers by André Mateus Breakdown of academic impact, for papers by Diógenes Santiago Santos Breakdown of academic impact, for papers by Sanjib Bhakta Breakdown of academic impact, for papers by Michael N. Gwynn Breakdown of academic impact, for papers by Yusuf Akhter Breakdown of academic impact, for papers by Maya A. Farha
Rankless by CCL
2026